title: Dopamine induces optical changes in the cichlid fish lens.
abstract: The crystalline lens in the cichlid fish Aequidens pulcher undergoes a transformation of its optical properties every dawn and dusk as the eye adapts to changes in light conditions. During dusk the transformation result in an increase of the refractive power in the lens cortex, the outermost 40 percent. The change is thought to match the optical properties of the lens to the requirements of the retina. Using a short term in vitro lens culturing system together with optical measurements we here present data that confirm that the optical properties of the lens can change within hours and that dopamine influences the optical properties of the lens. Dopamine yields dose-dependent decrease of the refractive power in the lens cortex. The D1-agonist SKF-38393 induces a similar decrease of the refractive power in the cortex, while the D2-agonist quinpirole has no effect. The effect of dopamine can be blocked by using the D1-antagonist SCH 23390. Our results suggest that dopamine alone could be responsible for the light/dark adaptive optical changes in the lens, but the involvement of other signaling substances cannot be ruled out.
authors.affiliation: Department of Biology, Lund University, Lund, Sweden. marcus.schartau@cob.lu.se
authors.forename: J Marcus
authors.initials: JM
authors.lastname: Schartau
authors.forename: Ronald H H
authors.initials: RH
authors.lastname: Kröger
authors.forename: Bodil
authors.initials: B
authors.lastname: Sjögreen
mesh_terms: D000222:Adaptation, Physiological; D000818:Animals; D023681:Cichlids; D002940:Circadian Rhythm; D004298:Dopamine / Q000494:pharmacology*; D007904:Lens Cortex, Crystalline; D007908:Lens, Crystalline / Q000187:drug effects*; D008027:Light; D012029:Refraction, Ocular / Q000187:drug effects
chemical_list: D004298:Dopamine
references.citation: J Gen Physiol. 2008 Apr;131(4):293-305
references.pmid: 18378798
references.citation: Curr Biol. 2009 Jan 27;19(2):122-6
references.pmid: 19147355
references.citation: Mol Pharmacol. 1993 Dec;44(6):1113-8
references.pmid: 8264547
references.citation: Prog Brain Res. 2001;131:477-85
references.pmid: 11420964
references.citation: J Exp Biol. 2006 Jan;209(Pt 1):18-25
references.pmid: 16354774
references.citation: Am J Physiol. 1999 Feb;276(2):C426-34
references.pmid: 9950770
references.citation: J Exp Biol. 2008 May;211(Pt 10):1559-64
references.pmid: 18456882
references.citation: Neurosci Lett. 2001 Mar 16;300(3):129-32
references.pmid: 11226628
references.citation: Physiol Meas. 2009 Oct;30(10):1061-73
references.pmid: 19738316
references.citation: Semin Cell Dev Biol. 1998 Jun;9(3):311-8
references.pmid: 9665867
references.citation: J Biol Chem. 1997 Jan 31;272(5):2778-87
references.pmid: 9006917
references.citation: Vis Neurosci. 1990 Aug;5(2):143-9
references.pmid: 2278941
references.citation: J Neurochem. 1989 Sep;53(3):870-8
references.pmid: 2547905
references.citation: J Gen Physiol. 1994 Mar;103(3):487-99
references.pmid: 8195784
references.citation: J Exp Biol. 2007 Aug;210(Pt 16):2923-31
references.pmid: 17690241
references.citation: J Comp Physiol A. 1999 Apr;184(4):361-9
references.pmid: 10377973
references.citation: Am J Physiol Cell Physiol. 2003 Dec;285(6):C1475-82
references.pmid: 12917107
references.citation: J Membr Biol. 2007 Mar;216(1):1-16
references.pmid: 17568975
references.citation: J Exp Biol. 2008 Sep;211(Pt 17):2752-8
references.pmid: 18723531
references.citation: Vis Neurosci. 1997 May-Jun;14(3):493-505
references.pmid: 9194316
references.citation: Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1393-402
references.pmid: 15790907
references.citation: Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5667-71
references.pmid: 8516316
references.citation: Biochim Biophys Acta. 1989 Nov 17;986(1):8-10
references.pmid: 2554983
references.citation: Exp Eye Res. 2003 May;76(5):565-72
references.pmid: 12697420
references.citation: Biochim Biophys Acta. 2004 Mar 23;1662(1-2):96-101
references.pmid: 15033581